ASSETMARK, INC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.

Quarter-by-quarter ownership
ASSETMARK, INC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$3,000
+200.0%
20
+233.3%
0.00%
Q3 2020$1,0000.0%60.0%0.00%
Q2 2020$1,000
-99.4%
6
-99.7%
0.00%
-100.0%
Q1 2020$169,000
-35.7%
2,325
-7.8%
0.00%
-50.0%
Q4 2019$263,000
+721.9%
2,521
+695.3%
0.00%
Q3 2019$32,000
+3100.0%
317
+5183.3%
0.00%
Q2 2019$1,0000.0%60.0%0.00%
Q1 2019$1,0000.0%60.0%0.00%
Q4 2018$1,000
-50.0%
60.0%0.00%
Q3 2018$2,000
+100.0%
60.0%0.00%
Q2 2018$1,0000.0%60.0%0.00%
Q1 2018$1,000
-99.3%
6
-99.4%
0.00%
-100.0%
Q4 2017$145,000
+339.4%
1,056
+336.4%
0.00%
Q3 2017$33,000
+6.5%
242
-5.5%
0.00%
Q2 2017$31,000
+14.8%
256
-0.4%
0.00%
Q1 2017$27,000
-6.9%
257
-10.5%
0.00%
Q4 2016$29,0000.0%287
+1.1%
0.00%
Q3 2016$29,000
-23.7%
284
-10.1%
0.00%
-100.0%
Q2 2016$38,000
+153.3%
316
+129.0%
0.00%
Q1 2016$15,000
+650.0%
138
+626.3%
0.00%
Q4 2015$2,000190.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders